Delivery Order SPE2DB22D3401-SPE2DB25FT2ME

Award Date 3/6/25
Potential Completion Date 3/7/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4,559,406,389 units of Naloxone HCl 4 mg Nasal Spray to the Defense Logistics Agency (DLA). The award, valued at $3,854.16, was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a period of performance through December 19, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of 4,567,222,939 units of Naloxone HCL 4 mg Nasal Spray 2S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,152.12, was awarded on February 10, 2025 to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price pricing type and runs through February 11, 2025. This contract is a delivery order under a larger...
This federal contract award is for the delivery of 4,560,559,581 units of Naloxone HCl 4 mg Nasal Spray to the Defense Logistics Agency (DLA). The contract, valued at $3,045.39, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 12, 2023. This contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award is for the delivery of 4,561,377,676 units of Naloxone HCl 4 mg Nasal Spray to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 29, 2023, with a completion date of June 30, 2023. The contract has a ceiling value of $2,047.78 and is a Firm Fixed Price Delivery Order. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp holds...
This federal contract award is for the delivery of 4,563,744,164 units of Naloxone HCL 4 mg Nasal Spray to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a firm fixed price of $5,364.40 and a completion date of February 23, 2024. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. This award is placed under an indefinite delivery contract (IDC) with a...
This federal contract award is for the delivery of 4,563,299,256 units of Naloxone HCL 4 mg Nasal Spray. The $9,713.59 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of January 11, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as...
This federal contract award is for the delivery of 4,558,909,494 units of Naloxone HCL 4 mg Nasal Spray 2's, procured by the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on October 27, 2022 with a ceiling value of $17,371.69. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,561,054,366 units of Naloxone HCL 4 mg Nasal Spray. The Firm Fixed Price contract, valued at $3,655.91, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999 through November 2026. This IDC enables the efficient procurement of a comprehensive range of...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of 4,566,749,486 units of Naloxone HCL 4 mg Nasal Spray. The firm-fixed-price delivery order has a ceiling value of $2,086.45 and a completion date of December 18, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor with no set-aside designation indicated. The contract is an Indefinite Delivery Contract (IDC) valued at $999,999,999 through...
This federal contract award is for the delivery of 4,565,803,531 units of Naloxone HCL 4 mg Nasal Spray by Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,143.85 Firm Fixed Price delivery order was awarded on September 13, 2024, with a completion date of September 16, 2024. The contract is being issued by the Defense Logistics Agency (DLA), a defense agency, and does not utilize any set-aside requirements. Amerisourcebergen holds a...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB25FT2ME
    Delivery Order

This federal contract award is for the delivery of 4,567,491,157 units of Naloxone HCL 4 mg Nasal Spray 2s, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $1,304.16, is a firm fixed-price delivery order with a period of performance running through March 7, 2025. The contract was not set aside for any specific business category. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that maintains significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued at $999,999,999 and $750,000 respectively, for the provision of a comprehensive range of pharmaceutical products and medical supplies to support federal healthcare programs.

Generated 6/5/25, 9:47 AM